🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "targeted action to address household expense challenges" in the upcoming financial statement.

In comments to media outlets, she stated that lowering inflation is a collective responsibility of both the administration and the central bank.

The UK's inflation rate is projected to be the most elevated among the Group of Seven developed nations this year and the following year.

Potential Energy Cost Measures

It is understood the administration could take action to bring down utility costs, for example by slashing the present 5% rate of value-added tax charged on energy supplies.

A further option is to cut some of the government charges currently added to bills.

Fiscal Limitations and Expert Expectations

The government will receive the next draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much scope there is for these measures.

The expectation from the majority of economists is that Reeves will have to announce tax rises or expenditure reductions in order to fulfill her self-imposed fiscal targets.

Previously on the same day, calculations indicated there was a £22bn deficit for the chancellor to address, which is at the more modest range of projections.

"There's a shared responsibility between the Bank of England and the government to further reduce some of the drivers of inflation," Reeves stated to reporters in Washington, at the annual meetings of the International Monetary Fund and global financial institution.

Revenue Commitments and Global Concerns

While much of the attention has been on likely tax increases, the chancellor said the latest information from the fiscal watchdog had not altered her commitment to election pledges not to raise rates on income tax, VAT or National Insurance.

She blamed an "unpredictable world" with growing international and trade issues for the fiscal revenue measures, likely to be directed on those "wealthiest."

International Economic Disputes

Addressing concerns about the United Kingdom's economic relations with China she said: "Our national security invariably are paramount."

Recent statement by China to increase trade restrictions on critical minerals and other resources that are essential for high-technology manufacturing led American leader Donald Trump to propose an extra 100% import tax on goods from China, raising the possibility of an full-scale trade war between the two global powers.

The American finance chief labeled the Chinese action "economic coercion" and "a international production power grab."

Questioned on accepting the American proposal to participate in its conflict with the Asian nation, Reeves said she was "extremely troubled" by China's actions and urged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "damaging for the global economy and causes additional challenges."

"In my view there are fields where we should address Chinese policies, but there are also important opportunities to sell into Chinese markets, including banking sector and other areas of the economy. We've got to maintain that equilibrium appropriate."

The Treasury chief also confirmed she was working with international partners "on our own essential resources strategy, so that we are less reliant."

NHS Drug Costs and Investment

The Chancellor also recognized that the cost the National Health Service pays for pharmaceuticals could rise as a consequence of current discussions with the Trump administration and its pharmaceutical firms, in return for lower tariffs and funding.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either halting or scrapping investments in the United Kingdom, with some attributing the modest returns they are receiving.

Recently, the Science Minister said the cost the health service spends on medicines would have to go up to prevent companies and drug research funding departing from the UK.

Reeves informed the BBC: "It has been observed due to the pricing regime, that medical research, innovative medicines have not been provided in the United Kingdom in the manner that they are in other European countries."

"Our aim is to ensure that people getting care from the National Health Service are able to access the best critical drugs in the globe. And so we are reviewing all of that, and... looking to obtain more funding into the UK."